CAT No: CP25584
CAS No:204246-17-3
Synonyms/Alias:Fmoc-D-Asp-OAll;204246-17-3;(3R)-3-(9H-fluoren-9-ylmethoxycarbonylamino)-4-oxo-4-prop-2-enoxybutanoic acid;C22H21NO6;(3R)-3-{[(9H-FLUOREN-9-YLMETHOXY)CARBONYL]AMINO}-4-OXO-4-(PROP-2-EN-1-YLOXY)BUTANOIC ACID;MFCD01074689;SCHEMBL15883753;DTXSID40427378;AKOS016844325;DS-6845;CS-0157987;F11941;(3R)-4-(allyloxy)-3-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}-4-oxobutanoic acid;N-alpha-(9-Fluorenylmethyloxycarbonyl)-D-aspartic acid alpha allyloxicarbonyl ester (Fmoc-D-Asp-OAll);
Chemical Name:N-alpha-(9-Fluorenylmethyloxycarbonyl)-D-aspartic acid alpha-allyl ester
4. The spatiotemporal control of signalling and trafficking of the GLP-1R
5. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.